WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma.
Saved in:
| Title: | WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma. |
|---|---|
| Authors: | Liang L; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China., Xu H; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Department of Oncology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China., Dong Q; Department of General Surgery, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China., Qiu L; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China., Lu L; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China., Yang Q; Department of Infectious Diseases and Hepatology, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China., Zhao W; Department of Oncology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China., Li Y; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Apr 11; Vol. 12, pp. 852000. Date of Electronic Publication: 2022 Apr 11 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35480109 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liang+L%22">Liang L</searchLink>; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Department of Oncology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.<br /><searchLink fieldCode="AU" term="%22Dong+Q%22">Dong Q</searchLink>; Department of General Surgery, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China.<br /><searchLink fieldCode="AU" term="%22Qiu+L%22">Qiu L</searchLink>; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China.<br /><searchLink fieldCode="AU" term="%22Lu+L%22">Lu L</searchLink>; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China.<br /><searchLink fieldCode="AU" term="%22Yang+Q%22">Yang Q</searchLink>; Department of Infectious Diseases and Hepatology, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China.<br /><searchLink fieldCode="AU" term="%22Zhao+W%22">Zhao W</searchLink>; Department of Oncology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Zhuhai Precision Medical Center, Zhuhai Hospital Affiliated With Jinan University (Zhuhai People's Hospital), Zhuhai, China.; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated With Jinan University), Zhuhai, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Apr 11; Vol. 12, pp. 852000. <i>Date of Electronic Publication: </i>2022 Apr 11 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35480109 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2022.852000 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 852000 Titles: – TitleFull: WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liang L – PersonEntity: Name: NameFull: Xu H – PersonEntity: Name: NameFull: Dong Q – PersonEntity: Name: NameFull: Qiu L – PersonEntity: Name: NameFull: Lu L – PersonEntity: Name: NameFull: Yang Q – PersonEntity: Name: NameFull: Zhao W – PersonEntity: Name: NameFull: Li Y IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 04 Text: 2022 Apr 11 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |